Why is Brooks Lab. falling/rising?

As of 03-Jul, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at 140.30, which reflects a decrease of 2.85 or 1.99%. The stock has been underperforming, having fallen for the last four consecutive days, resulting in a total decline of 7.7% during this period. Additionally, the stock's performance over the past week shows a significant drop of 6.47%, contrasting with the Sensex, which has only decreased by 0.62%. Despite having generated a return of 60.67% over the past year, the company's long-term fundamentals are weak, evidenced by a negative Return on Equity (ROE) of -10.2% and a declining net sales growth rate of -2.90% over the last five years. Furthermore, while institutional investors have increased their stake, the overall investor participation has decreased, indicating a lack of confidence among retail investors.
In the broader market context, Brooks Laboratories Ltd's recent performance has been notably weaker than the benchmark, as it has underperformed the Sensex by 5.67% over the past month, where the Sensex has gained 3.10%. The stock's volatility has been high, with an intraday volatility of 147.66%, suggesting uncertainty among investors. Although the stock has shown strong historical performance over longer periods, the current trends and weak fundamentals are contributing to its decline, making it less attractive compared to the broader market's stability and growth.